These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 275847)

  • 21. Nuclear estrogen receptor release from antiestrogen suppression: amplified induction of progesterone receptor in MCF-7 human breast cancer cells.
    Horwitz KB; Aiginger P; Kuttenn F; McGuire WL
    Endocrinology; 1981 May; 108(5):1703-9. PubMed ID: 7194178
    [No Abstract]   [Full Text] [Related]  

  • 22. Different nuclear binding sites for antiestrogen and estrogen receptor complexes.
    Ruh TS; Baudendistel LJ
    Endocrinology; 1977 Feb; 100(2):420-6. PubMed ID: 832632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of nuclear estrogen-binding sites in the rat uterus: a simple method for the quantitation of type I and type II sites by [3H]estradiol exchange.
    Markaverich BM; Williams M; Upchurch S; Clark JH
    Endocrinology; 1981 Jul; 109(1):62-9. PubMed ID: 7238414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiestrogens: effects of tamoxifen, nafoxidine, and CI-628 on sexual behavior, cytoplasmic receptors, and nuclear binding of estrogen.
    Etgen AM
    Horm Behav; 1979 Oct; 13(2):97-112. PubMed ID: 399606
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of neonatal exposure to the antioestrogens nafoxidine and CI-628 upon the development of the uterus in the prepubertal rat.
    Campbell PS; Satterfield PM
    J Reprod Fertil; 1988 May; 83(1):225-31. PubMed ID: 3397940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential blockade of estrogen-induced uterine responses by the antiestrogen nafoxidine.
    Galand P; Mairesse N; Roorijck J; Flandroy L
    J Steroid Biochem; 1983 Sep; 19(3):1259-63. PubMed ID: 6194375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of an anti-estrogen on neural estradiol binding and on behaviors in female rats.
    Wade GN; Blaustein JD
    Endocrinology; 1978 Jan; 102(1):245-51. PubMed ID: 743949
    [No Abstract]   [Full Text] [Related]  

  • 28. Estrogen receptor binding and growth of the reproductive tract.
    Clark JH; Hardin JW; McCormack SA
    Pediatrics; 1978 Dec; 62(6 Pt 2):1121-7. PubMed ID: 724349
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison between the action of estradiol and that of the antiestrogen U 11-100 A on the induction in the rat uterus of a specific protein (the induced protein).
    Mairesse N; Galand P
    Endocrinology; 1979 Nov; 105(5):1248-53. PubMed ID: 488011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oestrogen receptors and antagonism of steroid hormone action.
    Clark JH; Peck EJ; Anderson JN
    Nature; 1974 Oct; 251(5474):446-8. PubMed ID: 4371552
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition of estradiol-induced intranuclear inclusions by an anti-estrogen (nafoxidine) in mammotrophs of the Mongolian gerbil.
    Nickerson PA
    Proc Soc Exp Biol Med; 1975 Apr; 148(4):29-30. PubMed ID: 1129319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of tamoxifen, tamoxifen metabolites, and nafoxidine on adenosine 3',5'-monophosphate phosphodiesterase: correlations with growth inhibitory activities but not estrogen receptor affinities.
    Fanidi A; Courion-Guichardaz C; Fayard JM; Pageaux JF; Laugier C
    Endocrinology; 1989 Sep; 125(3):1187-93. PubMed ID: 2547579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
    Lippman M; Bolan G; Huff K
    Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human breast cancer: biologically active estrogen receptor in the absence of estrogen?
    Zava DT; Chamness GC; Horwitz KB; McGuire WL
    Science; 1977 May; 196(4290):663-4. PubMed ID: 193182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen-induced uterine responses and growth: relationship to receptor estrogen binding by uterine nuclei.
    Anderson JN; Peck EJ; Clark JH
    Endocrinology; 1975 Jan; 96(1):160-7. PubMed ID: 162876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative study of the behavior of an anti-estrogen and estradiol in uterine cells].
    Rochefort H; Capony F
    C R Acad Hebd Seances Acad Sci D; 1973 Apr; 276(15):2321-4. PubMed ID: 4197649
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of low dose continuous exposure to estradiol on the estrogen receptor (type I) and nuclear type II sites.
    Markaverich BM; Roberts RR; Alejandro M; Clark JH
    Endocrinology; 1984 Mar; 114(3):814-20. PubMed ID: 6697964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear association states of rat uterine oestrogen receptors as probed by nuclease digestion.
    Schoenberg DR; Clark JH
    Biochem J; 1981 May; 196(2):423-32. PubMed ID: 6274314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of estradiol and the antiestrogen tamoxifen on steroid hormone receptor concentration and nuclear ribonucleic acid polymerase activities in rat uteri.
    Davies P; Syne JS; Nicholson RI
    Endocrinology; 1979 Dec; 105(6):1336-42. PubMed ID: 499077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissociation of uterine eosinophilia and water imbibition from other estrogen-induced responses by nafoxidine pretreatment.
    Galand P; Tchernitchin N; Tchernitchin AN
    Mol Cell Endocrinol; 1985 Oct; 42(3):227-33. PubMed ID: 2412910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.